Skip to main content
OpenTrials

Clinical trial condition

Bronchial Neoplasms

Explore clinical trials studying Bronchial Neoplasms. Study availability and eligibility vary by location and protocol.

5,246 public trials 1,181 recruiting studies
Refine in advanced search Browse all conditions

Bronchial Neoplasms trial results

Recruiting

Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity

NCT01639508

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack Commack, New York, United States
View Trial Details
Recruiting

Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors

NCT05856981

Conditions
Adenocarcinoma, Bronchial Neoplasms, CRC, Colorectal Cancer, +47 more
Locations
  • Henry Ford Cancer Institute Detroit, Michigan, United States
  • Washington University Medical Campus St Louis, Missouri, United States
  • Gabrail Cancer & Research Center Canton, Ohio, United States
  • Virginia Cancer Specialists Fairfax, Virginia, United States
View Trial Details
Recruiting

PACCELIO - FDG-PET Based Small Volume Accelerated Immuno Chemoradiotherapy in Locally Advanced NSCLC

NCT06102057

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
Locations
  • Universitätsklinik Carl Gustav Carus der Technischen Universität Dresden Dresden, Germany
  • Universitätsklinikum Essen - Klinik für Strahlentherapie Essen, Germany
  • Medical Center - University Of Freiburg, Department of Radiation Oncology Freiburg im Breisgau, Germany
  • Universitätsmedizin Göttingen, Department for Radiotherapy and Radiooncology Göttingen, Germany
View Trial Details
Recruiting

A Phase 1 Study of LNCB74 in Advanced Solid Tumors

NCT06774963

Conditions
Adnexal Diseases, Advanced or Metastatic Solid Tumors, Biliary Tract Cancer, +37 more
Locations
  • Hoag Family Cancer Institute Newport Beach, California, United States
  • St. Elizabeth Healthcare Edgewood, Kentucky, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Washington University, Siteman Cancer Center St Louis, Missouri, United States
View all 14 locations
View Trial Details
Recruiting

A Phase 3 Study of Sunvozertinib Versus Placebo as Adjuvant Therapy in Patients With Early-Stage Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations or PACC Mutations After Radical Surgery

NCT07182682

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Beijing Cancer Hospital Beijing, China
  • Beijing Chest Hospital, Capital medical university Beijing, China
  • Cancer Hospital Chinese Academy of Medical Sciences Beijing, China
  • China-Japan Friendship hospital Beijing, China
View all 49 locations
View Trial Details
Recruiting

A Study of MT-4561 in Patients With Various Advanced Solid Tumors

NCT06943521

Conditions
Adenocarcinoma, Adnexal Diseases, Biliary Tract Cancer, +75 more
Locations
  • University of Southern California Los Angeles, California, United States
  • START Midwest Grand Rapids, Michigan, United States
  • The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Recruiting

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

NCT03556228

Conditions
Adenocarcinoma, Adenoid Cystic Carcinoma, Adenoma, +65 more
Locations
  • Providence Medical Foundation (site 209) Santa Rosa, California, United States
  • Hartford Hospital (site 210) Hartford, Connecticut, United States
  • The George Washington University Cancer Center (site 212) Washington D.C., District of Columbia, United States
  • Holy Cross Hospital (site 213) Fort Lauderdale, Florida, United States
View all 15 locations
View Trial Details

Related conditions